KDM4B inhibitors for the treatment of inflammatory diseases and disorders
US11834392B2 · kind B2 · utility
0Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2020 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Jan 30, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C235/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to KDM4B inhibitors, compositions comprising an effective amount of KDM4B inhibitors and methods for treating inflammatory diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.